Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc. financial statements

Unicycive Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 26.55M10-K
Cash and equivalentsUSD 29.2M10-Q
Total debtUSD 199KEODHD

Unicycive Therapeutics, Inc. financials on 6ix · Unicycive Therapeutics, Inc. on 6ix